Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial.
Authors
Slotman, B Jvan Tinteren, H
Praag, J O
Knegjens, J L
El Sharouni, S Y
Hatton, M
Keijser, A
Faivre-Finn, Corinne
Senan, S
Affiliation
Department of Radiation Oncology, VU University Medical Center, Amsterdam, NetherlandsIssue Date
2015-01-03
Metadata
Show full item recordAbstract
Most patients with extensive stage small-cell lung cancer (ES-SCLC) who undergo chemotherapy, and prophylactic cranial irradiation, have persistent intrathoracic disease. We assessed thoracic radiotherapy for treatment of this patient group.Citation
Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. 2015, 385 (9962):36-42 LancetJournal
LancetDOI
10.1016/S0140-6736(14)61085-0PubMed ID
25230595Type
ArticleLanguage
enISSN
1474-547Xae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(14)61085-0